Liposomes for Modulating Wiskott-Aldrich Syndrome Protein

M. Barda-Saad

Liposomes for Modulating Wiskott-Aldrich Syndrome Protein

M. Barda-Saad

The Mina and Everard Goodman Faculty of Life Sciences - at Bar-Ilan University

Research output: Contribution to journal › Article › peer-review

Abstract

Embodiments of the invention relate to liposomes comprising: a lipid bilayer having an internal cavity; a therapeutic agent within the internal cavity configured to modify expression or degradation of WASp in a cell; and a targeting moiety external to the lipid bilayer configured to target an extracellular domain of a cell. Embodiments of the invention relate to methods of treatment of disease comprising administering the liposomes. Novel pharmaceutical compositions are also disclosed.

Original language	American English
Pages (from-to)	962-962
Journal	US Patent App. 10,
Volume	154
State	Published - 28 Oct 2018

Cite this

@article{ca489a261761462792c64132ea4dabb4,

title = "Liposomes for Modulating Wiskott-Aldrich Syndrome Protein",

abstract = "Embodiments of the invention relate to liposomes comprising: a lipid bilayer having an internal cavity; a therapeutic agent within the internal cavity configured to modify expression or degradation of WASp in a cell; and a targeting moiety external to the lipid bilayer configured to target an extracellular domain of a cell. Embodiments of the invention relate to methods of treatment of disease comprising administering the liposomes. Novel pharmaceutical compositions are also disclosed.",

author = "M. Barda-Saad",

year = "2018",

month = oct,

day = "28",

language = "American English",

volume = "154",

pages = "962--962",

journal = "US Patent App. 10,",

}

TY - JOUR

T1 - Liposomes for Modulating Wiskott-Aldrich Syndrome Protein

AU - Barda-Saad, M.

PY - 2018/10/28

Y1 - 2018/10/28

N2 - Embodiments of the invention relate to liposomes comprising: a lipid bilayer having an internal cavity; a therapeutic agent within the internal cavity configured to modify expression or degradation of WASp in a cell; and a targeting moiety external to the lipid bilayer configured to target an extracellular domain of a cell. Embodiments of the invention relate to methods of treatment of disease comprising administering the liposomes. Novel pharmaceutical compositions are also disclosed.

AB - Embodiments of the invention relate to liposomes comprising: a lipid bilayer having an internal cavity; a therapeutic agent within the internal cavity configured to modify expression or degradation of WASp in a cell; and a targeting moiety external to the lipid bilayer configured to target an extracellular domain of a cell. Embodiments of the invention relate to methods of treatment of disease comprising administering the liposomes. Novel pharmaceutical compositions are also disclosed.

UR - http://scholar.google.com/scholar?num=3&hl=en&lr=&q=allintitle%3A%20Liposomes%20for%20modulating%20Wiskott-Aldrich%20syndrome%20protein%2C%20author%3ABarda-Saad&as_ylo=2018&as_yhi=&btnG=Search&as_vis=0

M3 - Article

VL - 154

SP - 962

EP - 962

JO - US Patent App. 10,

JF - US Patent App. 10,

ER -

Liposomes for Modulating Wiskott-Aldrich Syndrome Protein

Abstract

Other files and links

Fingerprint

Cite this